The company’s upcoming earnings report date is not yet available.
Is Itonis overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Itonis pay dividends?
Itonis does not currently pay dividends.
What is Itonis’s EPS estimate?
Itonis’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Itonis have?
Itonis has 1,523,409,800 shares outstanding.
Which hedge fund is a major shareholder of Itonis?
Currently, no hedge funds are holding shares in ITNS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Itonis
Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Mark H. Cheung
Employees
3
Website
www.itonisholdings.com
Address
22951 Mill Creek Drive, Laguna Hills, CA, 92653, US